Custom Search

Portfolio of Biotech Stocks: Arthritis

Here is a sample of 4 biotech stocks that provide arthritis treatments.

Biotech Stocks: Arthritis
Stock
Price Quote & Dividend
Recent Dividends
1-Yr Price Chart
Amgen
Antares Pharma
Horizon Pharma plc
Incyte Corporation
Price and dividend data from Quandl.


To inspect the performance of the Biotech Stocks: Arthritis portfolio, see the returns table and chart below. Portfolio values are computed using quarterly closes from Quandl.

The 3 included in the portfolio computations are: AMGN, ATRS and INCY. The current value of the portfolio assumes that $3,333.33 was invested (total of $10,000) in each at its closing quarterly price for the current date in 2007. HZNP was excluded from the portfolio computations because of insufficient price data.


Biotech Stocks: Arthritis - Return Results
Portfolio:
Biotech Stocks: Arthritis
Start date:
Jun-25-2007
Start value:
$10,000
End date:
Jun-25-2017
End value:
$94,290
Number prices
41
Minimum value occurred on Mar-31-2009
$5,193
Maximum value occurred on Jun-30-2017
$94,290
Total gain or loss (Start date to End date)
842.90%
Annualized gain or loss (Start date to End date)
1,621.50%
Total dollar value on End date of a $10,000 purchase made on Start date
$94,290
Average percent return for all possible buy/sell combinations
210.68%
Number returns
820
Number profitable returns (Winners)
720
Percent profitable returns
87.80%
Number unprofitable returns (Losers)
100
Percent unprofitable returns
12.20%
Winners to losers ratio
7.20
Portfolio Value Chart     Stock Return Calculator


Related Articles

Portfolio of Big Pharmaceuticals Stocks: Arthritis
Portfolio of Biotech Stocks
Portfolio of Biotech Stocks: Cancer
Portfolio of Biotech Stocks: Diabetes
Portfolio of Biotech Stocks: Hepatitis C
Portfolio of Dividend-Paying Pharmaceutical Stocks
Portfolio of Generic Drug Stocks